Opening book details…
About this Medicine article
PB2102: PHASE 2 RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PLAMOTAMAB COMBINED WITH TAFASITAMAB (TAFA) + LENALIDOMIDE (LEN) VS TAFA+LEN IN RELAPSED OR REFRACTORY DLBCL by J.-M. Michot; Y. Koh; P. Lee; J. Jin; R. Clynes; S. Kye; M. Chiarella; K. Patel is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- J.-M. Michot; Y. Koh; P. Lee; J. Jin; R. Clynes; S. Kye; M. Chiarella; K. Patel
- Published
- 2022
- Language
- EN
- Field
- Medicine (Health Sciences)
More by J.-M. Michot; Y. Koh; P. Lee; J. Jin; R. Clynes; S. Kye; M. Chiarella; K. Patel
Browse all works by J.-M. Michot; Y. Koh; P. Lee; J. Jin; R. Clynes; S. Kye; M. Chiarella; K. Patel